[Perspective for development of insulin sensitizers].
Kadowaki
Takashi
T
Department of Metabolic Diseases, Graduate School of Medicine, University of Tokyo.
D015195:Drug Design; D006801:Humans; D007004:Hypoglycemic Agents; D007333:Insulin Resistance; D000077205:Pioglitazone; D018160:Receptors, Cytoplasmic and Nuclear / Q000819:agonists*; D013844:Thiazoles / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D045162:Thiazolidinediones; D014157:Transcription Factors / Q000819:agonists*
D007004:Hypoglycemic Agents; D018160:Receptors, Cytoplasmic and Nuclear; D013844:Thiazoles; D045162:Thiazolidinediones; D014157:Transcription Factors; D000077205:Pioglitazone